Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease.
Haroutunian
V
V
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029.
Santucci
A C
AC
Davis
K L
KL
D000110:Acetylcholinesterase / Q000378:metabolism; D000544:Alzheimer Disease / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology* / Q000503:physiopathology; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D003543:Cysteamine / Q000494:pharmacology; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism; D006892:Hydroxydopamines; D007051:Ibotenic Acid; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D016627:Oxidopamine; D010830:Physostigmine / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values; D012701:Serotonin / Q000378:metabolism; D013004:Somatostatin / Q000378:metabolism
D006892:Hydroxydopamines; D007051:Ibotenic Acid; D012701:Serotonin; D013004:Somatostatin; D003543:Cysteamine; D016627:Oxidopamine; D003346:Corticotropin-Releasing Hormone; D010830:Physostigmine; D002795:Choline O-Acetyltransferase; D000110:Acetylcholinesterase; D004298:Dopamine; D009638:Norepinephrine